Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Single Blind Trial of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Therapeutic Angiogenesis

NCT00203203 is registered in ClinicalTrials.gov with Texas Heart Institute as lead sponsor.

NCT NCT00203203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Single Blind Trial of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance for Therapeutic Angiogenesis
Lead sponsor
Texas Heart Institute
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2004
Completion date
November 30, 2009
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic cardiomyopathy